Is a level III dissection necessary for a positive sentinel lymph node in melanoma?

Journal of Surgical Oncology

Volumn 105, Issue 3, 2012, Pages 225-228

  Namm, Jukes P ^a   Chang, Alfred E ^a   Cimmino, Vincent M ^a   Rees, Riley S ^a   Johnson, Timothy M ^a   Sabel, Michael S ^a  

^a UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

Author keywords

axillary lymph node dissection; melanoma; sentinel lymph node biopsy

Indexed keywords

ADULT; ARTICLE; CELLULITIS; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; LYMPH NODE DISSECTION; MAJOR CLINICAL STUDY; MALE; MELANOMA; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RECURRENT DISEASE; SENTINEL LYMPH NODE;

ADULT; AGED; AGED, 80 AND OVER; AXILLA; FEMALE; FOLLOW-UP STUDIES; HUMANS; LYMPH NODE EXCISION; LYMPHATIC METASTASIS; MALE; MELANOMA; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; POSTOPERATIVE COMPLICATIONS; RETROSPECTIVE STUDIES; SENTINEL LYMPH NODE BIOPSY; SKIN NEOPLASMS;

EID: 84860422478     PISSN: 00224790     EISSN: 10969098     Source Type: Journal    
DOI: 10.1002/jso.22076     Document Type: Article

References (25)

1. Morton DL, Thompson JF, Cochran AJ, et al.: Sentinel-node biopsy or nodal observation in melanoma. N Engl J Med 2006; 355: 1307-1317. (Pubitemid 44465459)
2. Garbe C, Hauschild A, Volkenandt M, et al.: Evidence-based and interdisciplinary consensus-based German guidelines: Systemic medical treatment of melanoma in the adjuvant and palliative setting. Melanoma Res 2008; 18: 152-160. (Pubitemid 351409353)
3. Essner R,: Surgical treatment of malignant melanoma. Surg Clin N Am 2003; 83: 109-156. (Pubitemid 36384363)
4. NCCN: Clinical Practical Guidelines in Oncology- Melanoma. 2011. (Accessed 12/21, 2010, at. http://www.nccn.org/profesionals/physician-gls/PDF/ melanoma.pdf).
5. Karakousis CP,: Therapeutic node dissections in malignant melanoma. Ann Surg Oncol 1998; 5: 473-482. (Pubitemid 28421745)
6. Meyer T, Merkel S, Gohl J, et al.: Lymph node dissection for clinically evident lymph node metastases of malignant melanoma. Eur J Surg Oncol 2002; 28: 424-430.
7. Serpell JW, Carne PW, Bailey M,: Radical lymph node dissection for melanoma. ANZ J Surg 2003; 73: 294-299. (Pubitemid 36649279)
8. Sakorafas GH, Peros G, Cataliotti L, et al.: Lymphedema following axillary lymph node dissection for breast cancer. Surg Oncol 2006; 15: 153-165. (Pubitemid 46241869)
9. Larson D, Weinstein M, Goldberg I, et al.: Edema of the arm as a function of the extent of axillary surgery in patients with stage I-II carcinoma of the breast treated with primary radiotherapy. Int J Radiat Oncol Biol Phys 1986; 12: 1575-1582. (Pubitemid 17175241)
10. Silberman H,: Axillary lymphadenectomy for breast cancer: Impact on survival. In:, Silberman H, Silberman A, editors. Surgical oncology: Multidisciplinary approach to difficult problems. London: Arnold; 2002. pp. 369-385.
11. Kiel K, Rademaker AW,: Early-stage breast cancer: Arm edema after wide excision and breast irradiation. Radiology 1996; 1998: 279-283. (Pubitemid 26009708)
12. Suneson BL,: Clinical incidence of lymphedema in breast cancer patients in Jonkoping County, Sweden. Eur J Cancer Care 1996; 5: 1-12.
13. Sondak VK, Taylor JM, Sabel MS, et al.: Mitotic rate and younger age are predictors of sentinel lymph node positivity: Lessons learned from the generation of a probabilistic model. Ann Surg Oncol 2004; 11: 247-258. (Pubitemid 40486764)
14. Frankel TL, Griffith KA, Lowe L, et al.: Do micromorphometric features of metastatic deposits within sentinel nodes predict nonsentinel lymph node involvement in melanoma? Ann Surg Oncol 2008; 15: 2403-2411.
15. Wrightson WR, Wong SL, Edwards MJ, et al.: Complications associated with sentinel lymph node biopsy for melanoma. Ann Surg Onc 2003; 10: 676-780.
16. Kretschmer L, Thoms KM, Peeters S, et al.: Postoperative morbidity of lymph node excision for cutaneous melanoma-sentinel lymphonodectomy versus complete regional lymph node dissection. Melanoma Res 2008; 18: 16-21. (Pubitemid 351628051)
17. de Vries M, Vonkeman WG, van Ginkel RJ, et al.: Morbidity after axillary sentinel lymph node biopsy in patients with cutaneous melanoma. Eur J Surg Oncol 2005; 31: 778-783. (Pubitemid 41194657)
18. Guggenheim MM, Hug U, Jung FJ, et al.: Morbidity and recurrence after completion lymph node dissection following sentinel lymph node biopsy in cutaneous malignant melanoma. Ann Surg 2008; 247: 687-693. (Pubitemid 351440621)
19. Gershenwald JE, Berman RS, Porter G, et al.: Regional nodal basin control is not compromised by previous sentinel lymph node biopsy in patients with melanoma. Ann Surg Oncol 2000; 7: 226-231. (Pubitemid 30215162)
20. Clary BM, Brady MS, Lewis JJ, et al.: Sentinel lymph node biopsy in the management of patients with primary cutaneous melanoma: Review of a large single-institution experience with an emphasis on recurrence. Ann Surg 2001; 233: 250-258. (Pubitemid 32106080)
21. Leiter U, Buettner PG, Bohnenberger K, et al.: Sentinel lymph node dissection in primary melanoma reduces subsequent regional lymph node metastasis as well as distant metastasis after nodal involvement. Ann Surg Oncol 17: 129-137.
22. Veenstra HJ, van der Ploeg IM, Wouters MW, et al.: Reevaluation of the locoregional recurrence rate in melanoma patients with a positive sentinel node compared to patients with palpable nodal involvement. Ann Surg Oncol 17: 521-526.
23. Balch CM, Durant JR, Bartolucci AA,: The impact of surgical quality control in multi-institutional group trials involving adjuvant cancer treatments. Ann Surg 1983; 198: 164-167. (Pubitemid 13027112)
24. Morton DL, Cochran AJ, Thompson JF, et al.: Sentinel node biopsy for early-stage melanoma: Accuracy and morbidity in MSLT-I, an international multicenter trial. Ann Surg 2005; 242: 302-313. (Pubitemid 41306595)
25. Spillane AJ, Cheung BL, Stretch JR, et al.: Proposed quality standards for regional lymph node dissections in patients with melanoma. Ann Surg 2009; 249: 473-480.